Aflac (NYSE: AFL) has announced a significant expansion of its share repurchase program. The company's Board of Directors has authorized the purchase of 100 million additional shares of common stock. This new authorization complements the existing 30.9 million shares remaining from the November 2022 authorization, bringing the total available for repurchase to approximately 130.9 million shares. The company plans to execute these repurchases through open market or negotiated transactions, with timing dependent on market conditions.\n\nAflac Incorporated (NYSE: AFL) today announced that its Board of Directors has authorized the purchase of up to 100 million shares of its common stock. This authorization is in addition to the 30.9 million shares as of June 30, 2025, that remained under the November 8, 2022 authorization, bringing the total number of shares available for purchase to approximately 130.9 million. The company anticipates that the repurchase of shares will be conducted from time to time in open market or negotiated transactions, depending on market conditions.\n\nThe company has helped provide financial protection and peace of mind for nearly seven decades to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products. In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance in terms of policies in force. The company takes pride in being there for its policyholders when they need us most, as well as being included in the World's Most Ethical Companies by Ethisphere for 19 consecutive years (2025) and Fortune's World's Most Admired Companies for 24 years (2025). In addition, the company became a signatory of the Principles for Responsible Investment (PRI) in 2021 and has been included in the Dow Jones Sustainability North America Index (2024) for 11 years. To find out how to get help with expenses health insurance doesn't cover, get to know us at aflac.com or aflac.com/español. Investors may learn more about Aflac Incorporated and its commitment to corporate social responsibility and sustainability at investors.aflac.com under 'Sustainability'.\n\nThe Company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements: difficult conditions in global capital markets and the economy, including inflation, defaults and credit downgrades of investments, global fluctuations in interest rates and exposure to significant interest rate risk, concentration of business in Japan, limited availability of acceptable yen-denominated investments, foreign currency fluctuations in the yen/dollar exchange rate, differing interpretations applied to investment valuation, significant valuation judgments in determination of expected credit losses recorded on the Company's investments, decreases in the Company's financial strength or debt ratings, decline in creditworthiness of other financial institutions, the Company's ability to attract and retain qualified sales associates, brokers, employees, and distribution partners, deviations in actual experience from pricing and reserving assumptions, ability to continue to develop and implement improvements in information technology systems and on successful execution of revenue growth and expense management initiatives, interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality, integrity or privacy of sensitive data residing on such systems, and uncertainty regarding the impact of the incident involving unauthorized access to the Company's network in June 2025, subsidiaries' ability to pay dividends to the Parent Company, inherent limitations to risk management policies and procedures, operational risks of third-party vendors, tax rates applicable to the Company may change, failure to comply with restrictions on policyholder privacy and information security, extensive regulation and changes in law or regulation by governmental authorities, competitive environment and ability to anticipate and respond to market trends, catastrophic events, including, but not limited to, as a result of climate change, epidemics, pandemics, tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, major public health issues, terrorism or other acts of violence, and damage incidental to such events, ability to protect the Aflac brand and the Company's reputation, ability to effectively manage key executive succession, changes in accounting standards, level and outcome of litigation or regulatory inquiries, allegations or determinations of worker misclassification in the United States.\n\nHow many new shares did Aflac's Board authorize for repurchase in August 2025? Aflac's Board of Directors authorized the purchase of 100 million additional shares of its common stock.\n\nWhat is the total number of shares available for repurchase under Aflac's buyback program? After the new authorization, Aflac has approximately 130.9 million shares available for repurchase, combining the new 100 million shares with 30.9 million remaining from the November 2022 authorization.\n\nHow will Aflac execute its share repurchase program? Aflac plans to conduct the share repurchases through open market or negotiated transactions, with timing based on market conditions.\n\nHow many shares remained available from Aflac's November 2022 share repurchase authorization? As of June 30, 2025, 30.9 million shares remained available from Aflac's November 8, 2022 share repurchase authorization.

Aflac Boosts Share Repurchase Power to 130.9M Shares in Major Expansion

Aflac Incorporated has authorized the purchase of an additional 100 million shares of its common stock, bringing the total available for repurchase to approximately 130.9 million shares. This includes the 30.9 million shares remaining from its November 2022 authorization. The company plans to execute the repurchases through open market or negotiated transactions, depending on market conditions. Aflac, a global provider of supplemental health insurance in the U.S. and medical insurance in Japan, is recognized for its corporate responsibility, being named to the World's Most Ethical Companies list for 19 consecutive years and Fortune's World's Most Admired Companies for 24 years. It is also a signatory of the Principles for Responsible Investment and included in the Dow Jones Sustainability North America Index for 11 years.